AstraZeneca Whittles Down Seroquel Case

In an increasingly bitter dispute in the multidistrict litigation over antipsychotic drug Seroquel, AstraZeneca LP asked a federal court on Tuesday to force the plaintiffs to substitute a case scheduled for...

Already a subscriber? Click here to view full article